CAAS Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-166,317	Closed	-$3.14M	–	631
2021 Q2	$3.14M	Buy	+166,317	New	+$3.14M	0.05%	123
2020 Q4	–	Sell	-35,792	Closed	-$561K	–	486
2020 Q3	$561K	Sell	35,792 -81,622	-70%	-$1.28M	0.01%	217
2020 Q2	$2.06M	Buy	+117,414	New	+$2.06M	0.07%	90